- Changes in cardiovascular-related health behaviors during the COVID-19 pandemic
-
Kim E, Jung CH, Kim DJ, Ko SH, Lee HY, Lee KY, Kang DR, Ryu SK, Lee WY, Rhee EJ, Kim HC
- KMID: 2540036
- Cardiovasc Prev Pharmacother.
- 2023 Jan;5(1):15-23.
- doi: 10.36011/cpp.2023.5.e2
Background: The COVID-19 pandemic has been the most pressing health challenge in recent years. Meanwhile, prevention for other diseases, such as cardiovascular disease (CVD) has been less prioritized during the... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse reactions to antiarrhythmic drugs
-
Do U
- KMID: 2540035
- Cardiovasc Prev Pharmacother.
- 2023 Jan;5(1):1-14.
- doi: 10.36011/cpp.2023.5.e1
There are various types of adverse reactions to antiarrhythmic drugs (AADs). Proarrhythmia, which refers to an exacerbation of the preexisting arrhythmia or occurrence of a new arrhythmia, may occur under... -
- CITED
-
- Close
- SHARE
-
- Close
- Modifiable risk factors for coronary artery disease in the Indonesian population: a nested case-control study
-
Hartopo AB, Inggriani MP, Jhundy BW, Fachiroh J, Rosha PT, Wardani RK, Dewi FST
- KMID: 2540037
- Cardiovasc Prev Pharmacother.
- 2023 Jan;5(1):24-34.
- doi: 10.36011/cpp.2023.5.e3
Background: There is a lack of data on modifiable coronary artery disease (CAD) risk factors in the Indonesian population, hindering the implementation of assessments and prevention programs in this population.... -
- CITED
-
- Close
- SHARE
-
- Close
